Sponsor Pipeline

YolTech Therapeutics Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT07587021
Study of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1 (PH1)		 Recruitment opened
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07587021 Study of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1 (PH1) Primary Hyperoxaluria Type 1 Recruiting
Phase 1/2
NCT06539208 A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to… Transthyretin Amyloidosis Polyneuropathy Recruiting
Disease Areas
Amyloidosis (1)
Get alerts when YolTech Therapeutics Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free